Clinical Development & Pipeline Programs Athira’s drug development pipeline includes potential first-in-class and next-generation novel small molecule drug candidates designed to promote the ...

Data from Eloxx's proof-of-concept trial in patients with nonsense mutation Alport Syndrome (NMAS) presented in late-breaking presentation at America ...

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. ("Terns” or the "Company”) (Nasdaq: TERN), a clinical-stage ...

Water and the bad smelling molecule hydrogen sulfide do not seem to have a lot in common at first sight. However, when ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...

Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth.

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today ...

Nine-month Results Remain On Track for Net ProfitAd Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, November 11, 2024-Addex ...

Oil and gas wells typically leave behind 85% or so of available resources. Enhanced oil and gas recovery is key to more ...

(Created with Biorender.com) ArcZ, small RNA that regulates ArcA/B regulon ... A critical player in these processes is the ...